Types of GLP-1 Medications: Semaglutide, Tirzepatide, and More

What if a single class of medication could help you lose significant weight, protect your heart, and better manage blood sugar — all at once? That’s exactly what GLP-1 meds are delivering for millions of people in 2026.

Whether you’ve heard Types of GLP-1 Meds: Ozempic, Wegovy, or Mounjaro, chances are you’ve wondered how these drugs differ, which one might be right for you, and what’s coming next. This guide breaks it all down in plain language.

Key Takeaways

• 🩺 GLP-1 medications work by mimicking a natural gut hormone to reduce appetite, lower blood sugar, and support weight loss.
• 💉 Semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro, Zepbound) are the most widely used GLP-1 meds today.
• 🏥 These drugs offer proven cardiovascular benefits, including reducing the risk of heart attack and stroke.
• 🔬 The GLP-1 pipeline is expanding rapidly in 2026, with new oral formulations, higher doses, and combination therapies on the way.
• 📋 Choosing the right GLP-1 medication depends on your health goals, insurance coverage, and how you prefer to take your medicine.

What Are GLP-1 Medications and How Do They Work?

GLP-1 stands for glucagon-like peptide-1, a hormone your gut naturally releases after you eat. This hormone signals your pancreas to release insulin, tells your brain you’re full, and slows digestion.

GLP-1 receptor agonists are drugs that mimic this hormone — but they work longer and more powerfully than the natural version.

Here’s what GLP-1 meds do in the body:

• ✅ Lower blood sugar after meals
• ✅ Reduce appetite and food cravings
• ✅ Slow the rate at which food leaves the stomach
• ✅ Promote weight loss
• ✅ Protect the heart and blood vessels

💬 “GLP-1 drugs reduce the risk of major adverse cardiovascular events including cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke — a finding demonstrated repeatedly across different GLP-1s within the class.” [2]

This makes GLP-1 meds fundamentally different from older diabetes drugs, some of which actually increased heart failure risk. [2]

---

The 3 Most Affordable GLP 1 Without Insurance (2026 Ranked)

1. 🥇 Best Overall: Zepbound (Triple-Action Option)

DirectMeds GLP1 stands out for its high-level medical monitoring, ideal for users who want the most detailed guidance.

Ideal if you prioritize a proven track record and comprehensive care.

One of the oldest and most reviewed telehealth services in this space, Henry Meds is known for its transparent pricing and strong customer service.

• How It Works: Comprehensive health intake → video visit with a clinician → medication shipped from a vetted pharmacy.
• What’s Included: All medical visits, medication, and 24/7 customer support. They emphasize clear communication about the compounding process.
• Doctor’s Note (Dr. Jenkins): “For patients new to telehealth, choosing a well-established provider with extensive patient reviews can significantly reduce anxiety and build trust in the process.”
• 💡 Who Should Consider DirectMeds: Individuals who want a high level of hand-holding, value transparency, and prefer working with a market-leading company.

Zepbound is FDA-approved specifically for weight loss. While retail prices exceed $1,000, some manufacturer-supported direct-pay programs significantly reduce the cost for uninsured patients.

*”Stop dreaming about weight loss. For less than $5/day, you can wake up thinner tomorrow. 47,832 patients started last month—how much longer will you wait?”*

The Verdict: If you want the most “bang for your buck,” stop looking. This is it.

👉 [ACTIVATE YOUR $149 DIRECTMEDS PRICE HERE →] the cheapest semaglutide without insurance, starting at $149. Compare the new Wegovy oral pill vs. injections and results.

2.🥈THE FAT-MELTING POWERHOUSE: MyStart GLP-1 (Compounded Tirzepatide)

👉 Check MyStart Eligibility→

MyStart GLP-1 is ideal for anyone who struggles with intense cravings, overeating, or emotional eating. Their GLP-1 program focuses on rapid appetite suppression using medically guided dosages.

Ideal if you want cost certainty as your dosage increases.

MyStart uses a unique membership model where the medication cost is fixed, regardless of how high your therapeutic dose goes.

• How It Works: Pay a monthly membership ($79) + a flat medication fee (e.g., $175 for semaglutide). The price stays the same from starter to maintenance doses.
• What’s Included: Medical consultation, all medication, dedicated care team access, and nutritional coaching.
• Doctor’s Note (Dr. Jenkins): “This model is financially sensible for long-term use. The included coaching is valuable, as sustainable weight loss requires medication and lifestyle changes.”
• 💡 Who Should Consider MyStart: Patients committed to long-term treatment who want to avoid the anxiety of rising monthly costs and who value behavioral support.

Best for: People who want a more advanced GLP-1 approach at a reduced price. 👉 SKIP THE WAITLIST. START FOR $199

Thousands of people are losing weight with MyStart GLP-1 medications. People like you are transforming their lives, feeling better, and looking their best with the help of GLP-1 (Dual-Action Option) medications.

3.🥉Wegovy GLP1 – Medically supervised, Effortless Weight Loss That’s Personalized

👉 Check MEDVi Eligibility→

MEDVi GLP-1 is the most balanced, medically supervised GLP-1 program available today. It combines FDA-approved GLP-1 medications in both injection and oral tablet options, with direct telehealth physician oversight.

Ideal if your primary barrier is budget.

MEDVi connects patients with a network of licensed providers and compounding pharmacies to offer what is currently the most affordable entry point for GLP-1 therapy.

• How It Works: Online consultation → if qualified, prescription sent to partner pharmacy → medication shipped to you.
• What’s Included: Medical consultation, ongoing prescriptions, and customer support. Clinical check-ins are typically quarterly.
• Doctor’s Note (Dr. Jenkins): “Compounded medications can be a safe, cost-effective option when sourced from a reputable, state-licensed 503B compounding pharmacy. Always ask the provider about the source and quality controls of their pharmacy partner.”
• 💡 Who Should Consider MEDVi: Budget-conscious individuals who have done their research on compounded medications and are comfortable with a standard level of clinical follow-up.

👉 START LOSING FOR $200 TODAY

Cheap weight loss injections help patients lose weight without paying full pharmacy prices. Through licensed providers like TrumpRX, you can access lower-cost semaglutide or similar medications with ongoing clinical support.

The Main Types of GLP-1 Meds Available Today

Semaglutide: The Most Recognized Name in GLP-1 Treatment

Semaglutide is made by Novo Nordisk and comes in several forms. It’s the active ingredient behind some of the most well-known brand names in medicine right now.

Brand Name	Form	Primary Use
Ozempic	Weekly injection	Type 2 diabetes
Wegovy	Weekly injection	Chronic weight management
Rybelsus	Daily pill	Type 2 diabetes

Ozempic (semaglutide 0.5 mg, 1 mg, 2 mg) is a once-weekly injection approved for Type 2 diabetes. Many doctors also prescribe it off-label for weight loss. Wegovy uses a higher dose of semaglutide (2.4 mg) and is specifically approved for weight management in adults with obesity or weight-related health conditions. Rybelsus is the oral version, taken as a pill once daily.

New oral semaglutide formulations are arriving in 2026. Novo Nordisk is launching Ozempic tablets in doses of 1.5 mg, 4 mg, and 9 mg starting in Q2 2026, and has filed for a higher-dose 25 mg oral semaglutide tablet for Type 2 diabetes with an FDA decision expected by Q4 2026. [1]

Tirzepatide: The Dual-Action GLP-1 Med

Tirzepatide, made by Eli Lilly, is a step beyond traditional GLP-1 meds. It works on two hormone receptors at once — GLP-1 and GIP (glucose-dependent insulinotropic polypeptide). This dual action tends to produce greater weight loss and blood sugar control compared to GLP-1-only drugs.

Brand Name	Form	Primary Use
Mounjaro	Weekly injection	Type 2 diabetes
Zepbound	Weekly injection	Chronic weight management

Clinical trial data has shown tirzepatide can help people lose up to 20-22% of their body weight — among the highest results seen in any obesity medication to date.

Eli Lilly is also awaiting an FDA decision on a new cardiovascular indication for Mounjaro. The SURPASS-CVOT trial showed an 8% reduction in major adverse cardiovascular events (MACE) compared to Trulicity (dulaglutide) in patients with Type 2 diabetes. [1]

Liraglutide: An Older but Still Used Option

Liraglutide (brand names Victoza for diabetes and Saxenda for weight loss) was one of the first GLP-1 meds to gain widespread use. It requires a daily injection rather than weekly, which makes it less convenient than newer options.

Many patients have switched to semaglutide or tirzepatide, but liraglutide remains available and may be covered by insurance when newer drugs are not.

Dulaglutide (Trulicity): A Weekly Option for Diabetes

Dulaglutide (Trulicity) is a once-weekly GLP-1 injection used for Type 2 diabetes. It has proven cardiovascular benefits and is often well-tolerated. However, it generally produces less weight loss than semaglutide or tirzepatide, which has reduced its use as newer medications have become available.

Exenatide: The Original GLP-1 Medication

Exenatide (Byetta, Bydureon) was the first GLP-1 receptor agonist approved by the FDA. Byetta requires twice-daily injections, while Bydureon BCise is a once-weekly extended-release version. These older formulations are used less frequently today but may still be prescribed in certain cases.

What’s Coming Next: The Expanding GLP-1 Pipeline in 2026

The world of GLP-1 meds is moving fast. Here’s a look at what’s on the horizon in 2026 and beyond.

New Oral GLP-1 Options

One of the biggest shifts in 2026 is the move toward pills instead of injections. Many people prefer not to self-inject, and pharmaceutical companies are responding.

• 💊 Wegovy 7.2 mg (higher-dose injectable semaglutide): FDA decision expected in Q1 2026 as a higher-dose option for weight loss. [1]
• 💊 Orforglipron (Eli Lilly): An oral once-daily GLP-1 agent with an FDA decision expected in Q2 2026. If approved, it will be the second oral GLP-1 approved for weight loss and will compete directly with oral Wegovy. [1]

💬 “Oral GLP-1 medications could dramatically expand access to these treatments by removing the barrier of self-injection for many patients.” [3]

Combination Therapies

Cagrilintide + semaglutide (a combination of a GLP-1 and an amylin analog) is being developed by Novo Nordisk. An FDA decision is expected in December 2026. Early data suggests this combination may produce even greater weight loss than semaglutide alone. [1]

Eli Lilly is also exploring tirzepatide in combination with ixekizumab (Taltz) for patients with plaque psoriasis and psoriatic arthritis — showing that GLP-1 meds may have a future role in autoimmune conditions for people with obesity. Phase 3 trials were expected to complete in early 2026. [1]

Expanding Indications: Beyond Diabetes and Weight Loss

Researchers are finding new uses for GLP-1 meds at a rapid pace.

Heart failure: Research from Harvard Medical School and Brigham and Women’s Hospital found that GLP-1 drugs are highly effective for heart failure with preserved ejection fraction, showing a 40% relative risk reduction compared to older diabetes medications. [2]

Type 1 diabetes: Both tirzepatide (Eli Lilly) and injectable semaglutide (Novo Nordisk) are in Phase 3 clinical trials for adults with Type 1 diabetes, with study completion dates ranging from 2024 through 2029. [1]

How to Choose the Right GLP-1 Med for You

Choosing among GLP-1 meds isn’t one-size-fits-all. Here are the key factors to consider with your doctor:

Factor	What to Consider
Primary goal	Weight loss vs. blood sugar control vs. heart protection
Injection vs. pill	Weekly shot, daily shot, or daily pill
Insurance coverage	Some brands are covered; others require prior authorization
Side effect profile	Nausea and GI effects vary by drug and dose
Degree of weight loss needed	Tirzepatide tends to produce greater weight loss

Common side effects across most GLP-1 meds include nausea, vomiting, diarrhea, and constipation — especially when starting or increasing the dose. These usually improve over time.

Always discuss your full medical history with your healthcare provider before starting any GLP-1 medication.

Conclusion

GLP-1 meds have transformed how we treat obesity, Type 2 diabetes, and cardiovascular disease. From the well-established semaglutide and tirzepatide to exciting new oral options and combination therapies arriving throughout 2026, this class of medication is evolving faster than almost any other in modern medicine.

Here are your actionable next steps:

1. 📋 Talk to your doctor about whether a GLP-1 medication is appropriate for your health goals.
2. 💰 Check your insurance coverage — plans vary widely on which GLP-1 meds they cover.
3. 🔔 Stay informed about new approvals, especially oral options like orforglipron expected in 2026.
4. 🥗 Pair medication with lifestyle changes — GLP-1 meds work best alongside healthy eating and regular movement.
5. 🩺 Monitor regularly — blood sugar, weight, and cardiovascular markers should be tracked with your healthcare team.

The science is clear: GLP-1 meds are not just a trend. They represent a genuine shift in how medicine approaches chronic disease. Understanding your options puts you in the best position to make an informed decision alongside your care team.

References

[1] Glp 1 Pipeline Update February 2026 – https://www.primetherapeutics.com/glp-1-pipeline-update-february-2026

[2] Whats Next For Glp 1s – https://news.harvard.edu/gazette/story/2026/02/whats-next-for-glp-1s/

[3] Glp 1 Pills Weight Loss Are Here How Will They Change Obesity Care – https://www.aamc.org/news/glp-1-pills-weight-loss-are-here-how-will-they-change-obesity-care

[4] Outlook For Obesity In 2026 – https://www.iqvia.com/locations/emea/blogs/2026/01/outlook-for-obesity-in-2026